Royalty Report: Scientific & Technical Instruments, Drugs, Diagnostic – Collection: 26736

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Scientific & Technical Instruments
  • Drugs
  • Diagnostic
  • Security
  • Pharmaceuticals
  • Diagnostic Substances

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26736

License Grant
Caltech hereby grants to Licensee the following licenses (a) an exclusive license under the Exclusively licensed Patent Rights to make, have made, import, use, sell, and offer for sale, licensed Products in the Field throughout the world; and (b) a nonexclusive, license under the Technology to make, have made, import, use, sell, offer for sale, reproduce, distribute, display, perform, create derivative works of, and otherwise exploit Licensed Products in the Field throughout the world.

Licensee also has the right to grant sublicenses to third parties.

License Property
The technology involves Bacterial Endospore Quantification using Lathanide Dipicolinate.  Other technology includes imaging bacterial spores using Tb-DPA luminescence assay and APS imaging; and lateral flow immunoassay for bacterial spore detection using Lanthanide Luminescence.  Bacterial spore detection / bio-terrorism detection technology – proprietary products, processes and services for use in the detection of pathogens, spores, and biological warfare agents.

Inventions described in CIT-3596 and CIT-3596-PCT that are not subject to this license
NPO 30444 117/2002 Live/Dead Assay for Bacterial Spores
NPO 30642 7/11/2002 Imaging Bacterial Spores Using Tb-DPA Luminescence Assay and APS Imaging
NPO 30684 9127/2002 Unattended Monitoring of Aerosolized Bacterial Spores
NPO 30469 11812002 Lateral Flow Immunoassay for Bacterial Spore Detection using Lanthanide Luminescence

Field of Use
Field means detection of pathogens, spores, and biological warfare agents.

IPSCIO Record ID: 26742

License Grant
The Company has the exclusive right from the University to the use the patented technology in the security market (including drugs/explosives and biohazard detection), in the hardware and software markets (including pattern detection process controls), and in the healthcare market (including human analyte quantification and detection), but not for monitoring the quality of lubricating fluids.  Exclusive license for the security, hardware, software, and healthcare fields was granted to develop and market a proprietary line of sensors to detect the presence of bio-terrorism threats, explosives and contraband narcotics. Licensee is a U.S. corporation, licensor a U.S. university.
License Property
The technology is in development stage with the development of a prototype for a handheld device that will detect anthrax spores in conjunction with a contract manufacturer that it plans to use to manufacture the product.  It is a noninvasive or remote mode of detection that provides an instantaneous response.

IPSCIO Record ID: 6220

License Grant
Licensor hereby grants to Licensee, and Licensee accepts, an exclusive worldwide license under the Patent Rights to make and have made, to use and have used, to research and have researched, to develop and have developed, to commercialize and have commercialized, to manufacture and have manufactured, to promote and have promoted, to practice and have practiced, to sell and have sold, to offer to sell, to export and have exported, and to import and have imported any Licensed Products.
License Property
The term “Licensed Products” shall mean any product, composition, method or process which, in the course of manufacture, use, practice, sale or import is (a) within the scope of one or more claims of the Patent Rights; or (b) A product containing any one or more of the following or similar elements and which is intended to be used as part of any product, composition, method or process which is within the scope of one or more claims of the Patent Rights (i) analytical chemistry media (i.e. TLC plates); (ii) luminescent bacteria for detection (stabilized); (iii) chemicals and reagents for performing steps covered under the Patent Rights; (iv) detection devices or media; and/or (v) Instruction manual describing or inducing one to perform the steps covered under the Patent Rights.

The term “Patent Right(s)” shall mean Luminous Bacteria and Methods for the Isolation, Identification and Quantification, of Toxicants described in U.S. Patent, 6,673,563 and Kit for the Isolation, Identification and Quantification of Toxicants described in U.S. Patent. 6,340,572, and Luminous Bacteria and Methods for the Isolation, Identification and Quantification of Toxicants described in U.S. Patent 6,017,722 as well as divisional, continuation and substitute patent applications claiming priority there from and any and all reissues, reexaminations and extensions thereof; and all foreign equivalents thereof.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.